Tel-Aviv Sourasky Medical Center
tasmc.org.ilLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
550
Active
45
Phase 3
36
Total enrollment
110,825
Pipeline matrix
Showing 17 of 17 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ultra Rapid Lispro | — | — | — | — | — | 1 | |
| Aspirin | — | — | — | — | — | 1 | |
| Fecal Microbial Transplant | — | — | — | — | — | 1 | |
| Auto Fecal Microbial Transplant (FMT) via enema | — | — | — | — | — | 1 | |
| ixazomib-pomalidomide-dexamethasone | — | — | — | — | — | 1 | |
| Rebif 44 MCG Per 0.5 ML Prefilled Syringe | — | — | — | — | — | 1 | |
| Mosunetuzumab is a bispecific monoclonal antibody targeting CD20 on B cells and CD3 on T cells, redirecting T cells to eliminate malignant B cells. | — | — | — | — | — | 1 | |
| Propranolol | — | — | — | — | — | 1 | |
| Saline | — | — | — | 3 | |||
| rhDNase I | — | — | — | — | — | 1 | |
| Morphine | — | — | — | 4 | |||
| Nacl 0.9% | — | — | — | — | — | 1 | |
| Transdermal fentanyl patch | — | — | — | — | — | 1 | |
| Metoprolol | — | — | — | — | — | 1 | |
| Plcacebo | — | — | — | — | — | 1 | |
| tDCS | — | — | — | — | — | 1 | |
| Everolimus (Afinitor) tablets with endocrine therapy | — | — | — | — | — | 1 |
Next readouts
- 2025-05-01
- 2025-07-01
- 2025-07-14
- 2025-09-21
- 2026-03-01
- 2026-08-31
- 2026-09
- 2026-12-31
- 2027-02
- 2027-05
Top conditions
- Pain11
- Parkinson Disease10
- Parkinson's Disease9
- Obesity8
- Crohn Disease7
- Ulcerative Colitis7
- Healthy7
- Rheumatoid Arthritis6
Frequently asked questions about Tel-Aviv Sourasky Medical Center
- How many clinical trials does Tel-Aviv Sourasky Medical Center have on ClinicalTrials.gov?
- Tel-Aviv Sourasky Medical Center is listed as the lead sponsor on 550 clinical trials in ClinicalTrials.gov, 45 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Tel-Aviv Sourasky Medical Center's trials are in Phase 3?
- 36 of Tel-Aviv Sourasky Medical Center's trials are in Phase 3, spread across 17 active drug programs.
- What therapeutic areas does Tel-Aviv Sourasky Medical Center focus on?
- Tel-Aviv Sourasky Medical Center's most-studied conditions on ClinicalTrials.gov are Pain, Parkinson Disease, Parkinson's Disease, Obesity, Crohn Disease.
- When are Tel-Aviv Sourasky Medical Center's next clinical trial readouts?
- Tel-Aviv Sourasky Medical Center has 10 upcoming primary-completion readouts tracked here; the soonest is “Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.”, expected around 2025-05-01.